Tae Gwan Park

This inventor holds 9 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Korea Advanced Institute of Science and Technology, Kaist IP Co., Ltd., Bioneer Corporation. Active years: 2003-2020.

USPTO Granted Patents = 9 (Patent Applications = 1)

% Patents Active = 66.7

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 2.8

ph-index = 6

Forward Citations = 204(Granted Patents)

Location History:

Taejon, KR (2003)
Taejon-si, KR (2003)
Yusong-ku, Taejon-si, KR (2007)
Daejeon, KR (2012 - 2020)

Company Filing History:

4 out of 2,781

Korea Advanced Institute of Science and Technology

Samyang Biopharmaceuticals Corporation

6. 2 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 2003-2020

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10597659 - Multi-conjugate of SiRNA and preparing method thereof (2020-03-24),

2. 9644209 - Multi-conjugate of siRNA and preparing method thereof (2017-05-09),

3. 9255269 - Multi-conjugate of siRNA and preparing method thereof (2016-02-09),

4. 8969543 - SiRNA-hydrophilic polymer conjugates for intracellular delivery of siRNA and method thereof (2015-03-03),

5. 8580946 - Multi-conjugate of siRNA and preparing method thereof (2013-11-12),

6. 8324365 - Conjugate for gene transfer comprising oligonucleotide and hydrophilic polymer, polyelectrolyte complex micelles formed from the conjugate, and methods for preparation thereof (2012-12-04),

7. 7163698 - Controlled drug delivery system using the conjugation of drug to biodegradable polyester (2007-01-16),

8. 6623729 - Process for preparing sustained release micelle employing conjugate of anticancer drug and biodegradable polymer (2003-09-23),

9. 6589548 - Controlled drug delivery system using the conjugation of drug to biodegradable polyester (2003-07-08),

Title: Innovations of Tae Gwan Park

Introduction

Tae Gwan Park is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of small interfering RNA (siRNA) technologies. With a total of nine patents to his name, Park's work has the potential to advance gene delivery systems and therapeutic applications.

Latest Patents

One of his latest patents is titled "Multi-conjugate of SiRNA and preparing method thereof." This invention relates to a multi-conjugate of siRNA, which is prepared through direct binding of double-stranded sense/antisense siRNA monomers or through indirect covalent bonding mediated by a cross-linking agent or a polymer. The method is characterized by its simplicity and efficiency, resulting in a siRNA multi-conjugate with a high molecular weight that is multiple times that of conventional siRNA. This high molecular weight leads to a high negative charge density, suggesting excellent ionic interaction with cationic gene carriers and enhanced gene delivery efficiency.

Career Highlights

Tae Gwan Park has worked at notable institutions, including the Korea Advanced Institute of Science and Technology (KAIST) and KAIST IP Co., Ltd. His research and innovations have positioned him as a key figure in the field of genetic engineering and biotechnology.

Collaborations

Throughout his career, Park has collaborated with several talented individuals, including Hye Jung Mok and Soo Hyeon Lee. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Tae Gwan Park's innovative work in the field of siRNA technology showcases his expertise and dedication to advancing biotechnology. His contributions have the potential to significantly impact gene delivery systems and therapeutic applications in the future.